tirzepatide medications FDA approves new version of diabetes drug Mounjaro to be sold for weight loss Tirzepatide | GLP1 | Medical

The SURPASS-2 trial directly compared the two for type 2 diabetes and found tirzepatide superior at all dose levels

Many individuals with fatty liver disease remain asymptomatic in early stages, with the condition often discovered incidentally through blood tests showing elevated liver enzymes or during imaging for unrelated concerns

But once youre pregnant, the official guidance is to stop taking the medication

The American Association of Clinical Endocrinology's 2022 consensus statement notes that GLP-1 receptor agonists are now first-line pharmacotherapy for obesity in patients who do not have contraindications, given their dual efficacy and cardiovascular data